RIVA-CAL D1000
Natural health product licensed in Canada
- Licence holder
- Laboratoire Riva Inc.
- NPN or DIN-HM
- 80072757
- Status
- Active licence
- Licence date
- 27 September 2016
- Revision date
- 28 June 2017
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Source : Cholécalciférol | 25 mcg | Not calculated |
| Calcium Source : Calcium Carbonate from Oyster Shell | 500 milligramme | Not calculated |
Non-medicinal ingredients
Cire de Carnauba, Triglycérides à chaîne moyenne, Stéarate de magnésium, Poly(éthylène glycol), ascorbate de sodium, Microcrystalline cellulose, Maltodextrine, gomme acacia, FD&C Blue No.2 Aluminum Lake, dl-alpha tocophérol, Dioxyde de titane, Sucrose, Talc, Modified food starch, Laque d'aluminium jaune FD&C No. 5, Crocarmellose sodium, Poly(alcool vinylique), Dioxyde de silicium, Laque d'aluminium jaune FD&C No. 6
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 6 years | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Vitamin D helps in the absorption and use of calcium and phosphorus and helps to prevent vitamin D deficiency. Vitamin D and Calcium helps in the development and maintenance of bones and teeth. Adequate calcium and vitamin D as part of a healthy diet, may help prevent bone loss/osteoporosis and reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80072757
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging